NAHL Group (NAH) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
5 Oct, 2026H1 performance and debt
H1 2024 revenue expected at £19.4m vs £21.0m in H1 2023; operating profit expected broadly in line with last year.
Net debt decreased 7% to £9.0m at 30 June 2024 from £9.7m at 31 December 2023.
Consumer legal services
National Accident Helpline actions reduced average enquiry acquisition cost materially towards normalised levels, alongside modest volume growth.
The Board considers lead-generation headwinds short term in nature.
Critical care and outlook
Bush & Co. delivered double-digit revenue and profit growth in H1 2024.
Potential sale of Bush & Co. remains under exploration, with strong interest from a wide variety of potential buyers.
July trading continued to plan; the Board remains confident of a full-year outturn in line with market expectations.
H1 results are expected in late September 2024.
Latest events from NAHL Group
- Q2 momentum held as Bush & Co sale talks ended and alternatives were explored.NAH
AGM 2025 - Strong cash generation offset Personal Injury weakness as Critical Care grew.NAHTrading update
- FY25 profit and cash generation surged, but lower NAL enquiries cloud FY26.NAHTrading update
- Higher H1 profit and cash flow offset subdued case management in Critical Care.NAHTrading update
- Critical Care growth and lower debt cushioned Personal Injury market weakness.NAHH1 2024
- Underlying PBT more than doubled as Critical Care grew and net debt declined despite PI market headwinds.NAHH2 2024
- Profit and cash generation strengthened, cutting net debt to a 10-year low.NAHH1 2025
- FY2025 profit and cash surged, but lower settlements may constrain 2026 cash flow.NAHH2 2025
- Profit and cash grew in H1; settlement lifts guidance as net cash is targeted by end-October.NAHH1 2026